Matthew Bowen
Chief Accounting Officer
Monte Rosa Therapeutics, Inc. (GLUE)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Matthew Bowen
Matthew Bowen is recorded as Chief Accounting Officer at Monte Rosa Therapeutics, Inc. (GLUE). Monte Rosa Therapeutics, Inc. reported in an 8-K filed February 10, 2026 that Matthew Bowen was appointed Corporate Controller and Principal Accounting Officer, effective April 3, 2026.
“Effective April 3, 2026, Matthew Bowen, currently an employee of the Company, will succeed Mr. Dunn as Corporate Controller and Principal Accounting Officer of the Company.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2026-04-03–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Monte Rosa Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Ajim Tamboli CFO
- Jennifer Champoux COO
- Sharon Townson CTO
- Philip Nickson General Counsel
- Andrew Schiff Board Member
- Anthony M. Manning, Ph.D. Board Member
- Anthony Manning Board Member
- Chandra P. Leo Board Member
- Eric A. Hughes, M.D., Ph.D. Board Member
- Jan Skvarka, Ph.D., MBA Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.